Article Citation: Rani K, Memon AR, Akram M, Memon PJ. Obesity; association of serum vitamin d levels. Professional Med J 2016;23(6):665-668.
The Corona Virus is the pandemic all over the world. This viral infection attacked all over the world like as disaster of viral infection which causes morbidity and mortality in different regions of world like Asia, Europe, and Africa etc. The different countries control the spread and complications of covid-19 like Acute Respiratory Distress Syndrome in well manner. In second wave there was again out break of covid-19 some regions of world. Here we discuss the causes of reoccurrence and their preventive measurements from our break effects of Covid-19.
Background: Vitamin B3 (Niacin) is known to decrease LDL‐cholesterol, and triglycerides, and increase HDL‐cholesterol levels. The evidence of benefits with niacin monotherapy or add‐on to statin‐based therapy is controversial. Aim: To determine the effects of vitamin B3 with statins on lipid profile of patients of angina pectoris with dyslpidemia. Study Design: Randomized control trial study. Place and Duration of Study: Department of Biochemistry, Shaikha Fatima Institute of Nursing & Health Sciences (SFINHS), Lahore with collaboration of Cardiology OPD of Shaikh Zayed Hospital Lahore from 1st November 2019 to 31st January 2020. Methodology: Seventy four diagnosed cases of angina pectoris with dyslipidemia were recruited with age range from 30 to 50 years. They were divided into two groups; Group I contained 36 patients as controlled group which was given treatment of angina with Tab. Rovista (statin) 10mg at dinner for treatment of dyslipidemia and Group II contained 38 patients as case study group which was given treatment of angina with Tab. Rovista (statin) 10 mg at dinner and tablet Vitamin B3 500 mg with single OD dose at day time for treatment of dyslipidemia for 8 weeks. Results: The mean serum cholesterol levels at zero level (before the start of treatment) of group I was 244 mg/dl and group II was 246 mg/dl, LDL of group I was 169 mg/dl while group II was 170 mg/dl and HDL of group I was 20 mg/dl while group II was 19 mg/dl . After the treatment group I which taken only statins for treatment of dyslipidemia the mean serum cholesterol levels was 210 mg/dl, LDL was 144 mg/dl and HDL was 26 mg/dl while the mean values of group II (taken statin as well as vitamin B3) serum cholesterol level was 192 mg/dl, LDL was 122 mg/dl and HDL was 44 mg/dl. The results shown there were significant effects of statin therapy along with vitamin B3 on serum LDL and serum HDL levels. Conclusion: There were significant effects of statin therapy along with vitamin B3 on serum LDL and Serum HDL levels. Key Words: Vitamin B3, Serum Cholesterol, Serum LDL &HDL
Background: Diabetes Mellitus is the global health problem all over the world. The millions of people facing morbidity and mortality due to poor glycemic control with their complications. Now a days many researchers working on the benefits of natural remedies to control and cure different diseases like diabetes, hypertension, dyslipidemia etc. Aims & Objectives: To evaluate the therapeutic efficacy of (combination of olive oil & garlic) on glycemic control with comparison conventional allopathic therapy. Study Design: Prospective Randomized control Trial (RCT). Setting: Institute of Biochemistry Sindh University Jamshoro. Period: Three months from 15th July to 15th October 2017. Methodology: Collaboration of diabetic clinic medical wards LUMHS Jamshoro. Total 160 patients recruited and divided into two groups control and case study group. Anti-diabetic drugs were given both group with same dose and balanced diet, formulated capsules containing 1.1 ml of olive oil & 500mgs of garlic powder were given only patients of case study group for 12 weeks. Fasting blood sugar levels were analyzed by glucose oxidase method at zero level, level – I, level – II, while HbA1c% was detected by micro lab at zero level & level – II. Results: The results of our study; shows that serum fasting level significantly (p value = <0.001) reduce in case study group as compared to control group, glycemic control significant (p= <0.001) better observed in case study group as compare with control group. Conclusion: Our study concluded that components of olive oil and garlic have hypoglycemic effects with good glycemic control. With proper usage of garlic and olive oil in diet of diabetic patients can maintain glycemic control with in normal limits.
Introduction: Diabetes mellitus and its complications are spreading with increased rate in Asian population especially in Pakistan. Uncontrolled diabetes can lead to different micro vascular complications. Cataract is one of the complications of diabetes which may lead to lens degenerative changes and visual impairment. G6PD plays a vital role in preventive measurements from cataract development in normal population. Objectives: This Study was designed to estimate G6PD levels in diabetic without ocular manifestations & diabetic cataract population. Methodology: This cross sectional comparative study was done at the Department of Biochemistry LUMHS Jamshoro in collaboration with the Diabetic clinic, Institute of Ophthalmology & Diagnostic Research Laboratory LUMHS Jamshoro. 100 diagnosed subjects of diabetes were selected by Non-Probability type of sample technique with consent of subjects and they were divided in to two groups Group A as control 50 diabetic subjects with out ocular manifestation while Group B as case study group contain 50 subjects of diabetes with cataract. The fasting blood glucose level was estimated by Hexokinase Method while G6PD level was measured by kit method on SD Biosensor while HbA1c(% ) was estimated by TTAB methodology. The data was statistically analyzed by SPSS 21. Results: The mean level of G6PD in Group A was 15.63±2.45 u/Hb while in group B it was 9.01±3.11 u/G HB. This result finally concluded that there was significantly (<0.05) decline of G6PD diabetic cataract as compared with diabetic without cataract. Conclusion: This study concluded that there was significant decline in G6PD level in diabetic cataract. It is also concluded that the estimation of G6PD level in diabetic population will be beneficial to take early preventive measurements against diabetic vascular complications.
Background: Proton Pump inhibitors (PPI) are widely used all over the world as therapeutic agents as well as prophylactic agent at different age groups for multiple gastrointestinal disorders etc. it inhibits the hydrogen potassium pump (H/K ATPase Pump). PPI interferes the calcium absorption and thus disturbs acid secretion which leads to decrease the calcium level in the body. Objective: The present design is to evaluate the effects of PPI on serum calcium level in rabbit model. Study Design: Randomized Control Trial/ Study on Rabbit Model. Place and Duration of Study: This experimental study was done at Department of Pharmacology Isra Medical University Hyderabad (November 2020 to March 2021 Material & Methods: A total 20 healthy male rabbits with weight between 1-2kg were included in this study. While female rabbits, ill rabbits and rabbits with weight less than 1kg were excluded from study. Ten rabbits were given omeprazole sachet of 20mg orally dissolve in water once a day and 10 rabbits were given sachet of esomeprazole of 20mg dissolve in water once a day upto 90 days regularly. At different levels of study blood samples were obtained from vein near ear of rabbits and samples were centrifuged for 10minutes to obtain the serum. Then serum was sent to Isra Diagnostic Laboratory for analysis of serum calcium levels of all samples at different levels of study. Results: Serum calcium levels of all rabbits were analyzed at three different levels of study, at zero level before starting of experiment, at level I after completion of one month of experiment and level II after the completion of three months of experiment. The normal serum calcium level in rabbits is 13-15mg/dl.8There was a significant decline in serum calcium level in Group A (Omeprazole Group), while in Group B (Esomeprazole Group) there was no significant relation between decreased serum calcium levels. Conclusion: The study concluded that there is significant relation of longterm usage of PPI on serum calcium level.
Background: Diabetes Mellitus is one of the alarming health hazardous indicator and with poor glycemic control, it will be dangerous for human health because it is more prone to development of different systemic & vascular complications. G6PD is one of the carbohydrate metabolic enzyme which prevent from oxidative stress and development of free radicals. Objective: The purpose of this research is to evaluate the level of G6PD in patients of type-2 diabetes mellitus with their different levels of glycemic control index. Methodology: This study was done at Department of Biochemistry LUMHS in collaboration with Diabetic clinic LUMHS and Diagnostic & Research Laboratory LUMHS Jamshoro. Total 100 diagnosed cases of type-2 diabetes were selected and divided into three groups with different categories of glycemic control index. The HbA1c% was measured by Bio Red Variant while G6PD was measured by standard G6PD quantitative measurement method at Diagnostic laboratory LUMHS using assay kit (SD Biosensor, Inc. Republic of Korea). Results: The G6PD significantly (p < 0.05) decline in diabetic patients with poor glycemic control having mean values of HbA1c% between 11-13%. Conclusion: This research study concluded that there is significant decline in G6PD in patients of diabetes mellitus with poor glycemic control. Estimation G6PD also can use as screening test in diabetic population to determine their genetic involvement. Keywords: Type-2 Diabetes Mellitus, HbA1c%, G6PD
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.